Text Size

Pacific Northwest Udall Center (PANUC) Clinical Core

This study is currently recruiting participants.
Verified October 2012 by University of Washington
Sponsor:
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT01720810
First received: October 31, 2012
Last updated: November 1, 2012
Last verified: October 2012
History of Changes
  Purpose

This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.


Condition
Parkinson Disease
Cognitive Impairment

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pacific Northwest Udall Center (PANUC) Clinical Core

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Washington:

Estimated Enrollment: 2000
Study Start Date: March 2010
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Participants fall into either of two categories: A clinical sample (CS) that is evaluated every 2-3 years or an annual sample (AS) that followed once yearly.

All subjects undergo the following procedures:

  • History and physical examination
  • Questionnaires about mood, activities of daily living, environmental exposures and demographic information.
  • Psychometric tests

Study companions may also be asked to complete questionnaires about the study subject regarding medical and psychiatric history, as well as activities of daily living.

Criteria

Inclusion Criteria:

  • Diagnosis of Parkinson disease
  • Over 18 years of age

Exclusion Criteria:

- Under 18 years of age

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01720810

Contacts
Contact: Marne Baca, BA 206.277.6977 marneb@uw.edu
Contact: Emily Ashmore, BS 206.277.3956 Emily.ashmore@staff.sibcr.org

Locations
United States, Washington
VA Puget Sound Health Care System Recruiting
Seattle, Washington, United States, 98108
Contact: Emily Ashmore, BS     206-277-3956     emily.ashmore@staff.sibcr.org    
Principal Investigator: James B Leverenz, M.D.            
Sponsors and Collaborators
University of Washington
  More Information

No publications provided

Responsible Party: University of Washington
ClinicalTrials.gov Identifier: NCT01720810     History of Changes
Other Study ID Numbers: UW HSD: 37855
Study First Received: October 31, 2012
Last Updated: November 1, 2012
Health Authority: United States: Federal Government
United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Parkinson Disease
Cognition Disorders
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013